Navigation Links
Sorrento Announces the Unexpected Death of its Chief Business Officer
Date:7/31/2014

SAN DIEGO, July 31, 2014 /PRNewswire/ -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE; Sorrento) today announced the death of Mr. Amar Singh, Chief Business Officer and Executive Vice President. Mr. Singh died suddenly and unexpectedly of apparent natural causes on July 30.

"Sorrento is deeply saddened and shocked by the loss of our dear friend and colleague. Our immediate thoughts go to Amar's family and friends," said Henry Ji, Ph.D., Sorrento's President and Chief Executive Officer.

Mr. Singh joined Sorrento in January 2014 from Synta Pharmaceuticals, where he served as SVP and Chief Business Officer since December 2010. Previously, Mr. Singh served as: Chief Operating Officer of Spectrum Pharmaceuticals, where he led the commercial and business development teams; VP and Chief Commercial Officer at Novacea responsible for securing partnerships; and Chief Commercial Officer at Abraxis where he led the launch of Abraxane®. Prior to Abraxis, Mr. Singh held multiple commercial leadership positions in the oncology franchise at Hoffman-La Roche for over 10 years. Mr. Singh holds an M.B.A. from the Stern School of Business at New York University and a B.A. from the University of North Carolina at Chapel Hill.

About Sorrento Therapeutics, Inc.
Sorrento is an oncology company developing new treatments for cancer and associated pain. Sorrento's most advanced asset Cynviloq™, the next-generation paclitaxel, commenced its registrational trial in March 2014 and is being developed under the abbreviated 505(b)(2) regulatory pathway. Sorrento is also developing RTX, a non-opiate TRPV1 agonist currently in a Phase 1/2 study at the National Institutes of Health to treat terminal cancer patients suffering from intractable pain. The Company has made signifi
'/>"/>

SOURCE Sorrento Therapeutics, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Sorrento Awarded Grant from the National Institutes of Health for the Development of a Small Molecule Myc Inhibitor
2. Sorrento Therapeutics to Present at the Biotech Showcase 2014 and the 7th Annual OneMed Forum SF2014 in San Francisco
3. Sorrento Therapeutics Completes Acquisition of Concortis Biosystems
4. Sorrento Enters into Definitive Agreement to Acquire Antibody Drug Conjugation Technology
5. Sorrento Therapeutics Adopts Stockholder Rights Plan
6. Sorrento Therapeutics Enters into Antibody and Vaccine Development Alliance for the Prevention and Treatment of Obesity
7. Sorrento Therapeutics Announces Closing of Public Offering of Common Stock
8. Sorrento Therapeutics Announces Pricing of Public Offering of 4,150,000 Shares of Common Stock and Listing on NASDAQ
9. Sorrento Therapeutics Secures Rights to Biomiga Diagnostics Therapeutic Drug Monitoring Device for Development of Personalized Paclitaxel Cancer Therapy
10. Sorrento Therapeutics Completes IgDraSol Merger
11. Sorrento Therapeutics to Present at Two Healthcare Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... DUBLIN, Ohio and MELVILLE, N.Y. ... (NYSE: CAH ), one of the world,s ... (NASDAQ: HSIC ), the world,s largest provider ... animal health and medical practitioners, today announced that the ... provide one of the most comprehensive service and product ...
(Date:11/21/2014)... 2014 /PRNewswire/-- CANTEL MEDICAL CORP. (NYSE: CMN ) announced ... will be presenting at the 26 th Annual Piper ... New York . The formal presentation is ... In addition, Mr. Krakauer and Jorgen B. Hansen , ... during the day. An audio webcast will ...
(Date:11/21/2014)... Nov. 20, 2014  The acceptance of two ... AAGL Global Congress demonstrates continued interest in the ... provide bowel control. One of the abstracts, presented by ... Division Chief of Urogynecology and Reconstructive Pelvic Surgery ... Award for Best Written Abstract on Urogynecology/Pelvic Floor ...
Breaking Medicine Technology:Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 2Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 3Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 4Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 5LIFE Study Prominently Featured at Minimally Invasive Gynecology Conference 2LIFE Study Prominently Featured at Minimally Invasive Gynecology Conference 3
... Nov. 9, 2010 As obesity rates and the ... the 2010 mHealth Summit in Washington D.C. is bringing ... discuss the opportunities to address pressing public health issues ... the pioneer in developing wearable body monitoring systems, recently ...
... 2010 The clinical practice guideline recently issued by ... spinal compression fractures has left the medical community scratching ... fractures (also called vertebral compression fractures or VCFS) are ... affects an estimated 44 million Americans, or 55 percent ...
Cached Medicine Technology:Results of Two New Clinical Studies Show Promise of Emerging Mobile Health Technology to Combat Obesity Epidemic 2Results of Two New Clinical Studies Show Promise of Emerging Mobile Health Technology to Combat Obesity Epidemic 3AAOS Clinical Guideline for Treating Spinal Compression Fractures Presents More Questions Than Answers for Medical Community 2AAOS Clinical Guideline for Treating Spinal Compression Fractures Presents More Questions Than Answers for Medical Community 3
(Date:11/22/2014)... (HealthDay News) -- A clinical trial of hydroxyurea therapy ... a year early because the results show it is ... and reduce the risk of stroke. The announcement ... centers in the United States and Canada, was made ... Blood Institute (NHLBI). Researchers compared monthly blood transfusions ...
(Date:11/22/2014)... HealthDay Reporter FRIDAY, Nov. 21, 2014 (HealthDay ... in an ambulance by a neurologist equipped with a CT ... patients get the clot dissolver -- tissue plasminogen activator (tPA) ... noted. For the best outcome, the drug needs to be ... researchers said. "The so-called ,golden hour, is associated with ...
(Date:11/21/2014)... CT (PRWEB) November 21, 2014 CRN ... a veteran radio industry sales professional to its award-winning ... brings 30 years of leadership and sales experience to ... and assume the title of Director of Strategy and ... Development, Robert O’Mara. , Heinemann will handle a wide ...
(Date:11/21/2014)... to make it tougher for people to misuse prescription ... approved a new hydrocodone tablet that,s designed to help ... brand name Vicodin -- is a powerful opioid painkiller ... addictions across the United States. The FDA said ... extended-release tablet to treat pain severe enough to require ...
(Date:11/21/2014)... they,ve mapped the genome -- the genetic "blueprint" -- of ... it might help others with this very rare infection. ... , the tapeworm was removed from the brain of a ... so rare worldwide and completely unexpected in this country that ... pulled out from the brain," study lead author Hayley Bennett, ...
Breaking Medicine News(10 mins):Health News:Sickle Cell Anemia Treatment So Successful in Kids That Trial Is Halted 2Health News:Special Ambulance Delivers Vital Stroke Care More Quickly 2Health News:Special Ambulance Delivers Vital Stroke Care More Quickly 3Health News:Radio Industry Veteran Joins CRN International’s Sales Organization in Detroit 2Health News:FDA Approves 'Abuse-Resistant' Narcotic Painkiller 2Health News:FDA Approves 'Abuse-Resistant' Narcotic Painkiller 3Health News:Ick! Tapeworm Infecting Man's Brain Yields Genetic Secrets 2
... cancer research. They say they have been able to grow cancer ... of cancer treatments, they hope. ,Liu Hua, a visiting ... had for years been able to grow cancer cells in laboratories, ... that doctors to whom he showed the tumour he had developed ...
... have shown in a laboratory study that revving up ... caused by a form of muscular dystrophy. ... Development, the researchers demonstrated that manipulating a genetic molecular ... mice with Duchenne muscular dystrophy, slowing the disease-associated muscle ...
... U.S. Food and Drug Administration (FDA) today announced that ... treat Parkinson’s disease, will voluntarily remove// these drugs from ... to patients’ heart valves. ,The products being ... by Valeant Pharmaceuticals, and two generic versions of pergolide ...
... in the development of vaccines for bird flu, clearly revolves ... bird flu, the H5N1 virus, which could mutate to pandemic ... the world have continually exchanged information with the WHO on ... of assisting scientists to be abreast with the genetic composition ...
... fellow scientists in Japan have developed a new system that ... to smog// and high ozone levels. ,Many volatile ... oxides, contribute to smog and ozone levels and are potentially ... ,Anil K. Sinha at the Toyota Central R&D Labs ...
... wake of persistent supply shortage, the World Health Organisation has ... undesirable practice of preying upon poorer nations by patients from ... transplants far exceeds supply, WHO said after a meeting of ... most sought-after organ with the 66,000 transplanted in 2005. That ...
Cached Medicine News:Health News:Switching Genes to Overdrive Improves Muscular Dystrophy Symptoms in Mice 2Health News:FDA Announces Voluntary Withdrawal of Pergolide Products 2Health News:Transplant Tourism on the Rise, Says WHO 2
Space-saving counter top model,User initiated manual defrost,Standard features (see above),Internal freezing compartment,Removable half-shelf in refrigerator,Two shelves in door,UL 471 Commercial Ref...
... of Type III Laboratory-grade Water, RiOs reverse ... to 8000 L/day of Type III laboratory-grade ... Purification and Control Unit, RiOs systems can ... total control of all parameters within the ...
... produce Type III, laboratory-grade pure water at ... directly with potable tap water and combine ... design that is easy to operate, reliable, ... produced at a low operating cost., Applications, ...
... Ultra Low Freezers -85C offer efficiency and ... Compressor life is extended by an energy-saving ... constant flow of refigerant. Heat is efficiently ... with three fans. Monitoring light to warn ...
Medicine Products: